Thursday, November 5, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· November 30, 2025

3 Non-AI Stocks to Buy: MRK, UPS, CVX

View original at nasdaq.com
3 Non-AI Stocks to Buy: MRK, UPS, CVX In this podcast, Motley Fool analysts Anthony Schiavone, Karl Thiel, and Tim Beyers discuss: Merk's $9.2 billion acquisition of Cidara Therapeutics.Earnings news from UPS and Chevron.Other investing tidbits…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • UPS is a buy with 7% dividend yield potentially enough to beat market over 5-10 years

    80% confidence
  • UPS is firmly in a turnaround and this quarter shows turnaround is in early stages of turning

    80% confidence
  • Chevron expects to return $10-20 billion annually to shareholders through 2030

    80% confidence
  • CF Industries unlikely to increase dividend in 2026 due to preference for buybacks and commodity price uncertainty

    80% confidence
  • UPS's better, not bigger strategy is progressing based on improved revenue per piece despite volume decline

    80% confidence
  • Stock Advisor's total average return is 1,004% compared to 194% for S&P 500

    80% confidence
  • Merck is not paying an outrageous amount for Cidara given the drug's broader potential and platform applications

    80% confidence
  • UPS expects to reduce expenses by $3.5 billion in 2025

    80% confidence
  • Chevron is a buy with 4.3% yield and expected 10% annual free cash flow growth through 2030 representing double-digit expected return

    80% confidence
  • $1,000 invested in Nvidia on April 15, 2005 would be worth $1,084,986

    80% confidence
  • Merck is attractively priced relative to rest of market

    80% confidence
  • Hasbro should not increase dividend in 2026, capital has better uses

    80% confidence
  • Wabtec will increase dividend in 2026 based on low 12% payout ratio and stated goal

    80% confidence
  • $1,000 invested in Netflix on December 17, 2004 would be worth $580,171

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Oncology Data Season and Biotech Capital Allocation: ESMO Readouts, Ivonescimab PDUFA, and Diverging Corporate Moves
Late-2026 biotech is driven by a dense catalyst calendar. ESMO 2026 delivers data from ivonescimab, Enhertu, R-DXd and bemarituzumab, and the FDA has set a 14 Nov PDUFA date for the ivonescimab BLA. Capital allocation is diverging. Krystal Biotech authorized a $400M buyback while lowering FY2026 spend guidance and pushing milestones into 2027. Spago is moving to delist from Nasdaq First North. The facts are clinical and corporate events, not AI or fintech, so the finance angle is limited to capital markets (buybacks, guidance, delistings, regulatory timelines).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,549 source documents archived
Query this data → isubstrate.com